BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in LFCR — Lifecore Biomedical, Inc. \De\
CIK 1107261
HOUSTON, TX
Position in LFCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$229,896
-$275,628 QoQ
Shares Held
61,800
0.0% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $35,934,652 across 16 Drug Manufacturers - Specialty & Generic names. LFCR ranks #14 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
411,373 | $9,297,029 | |
| 2 | PRGO |
PERRIGO Co plc
|
815,347 | $8,756,826 | |
| 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
330,457 | $6,473,652 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
48,000 | $2,481,120 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,620 | $1,553,607 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
440,493 | $1,546,130 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
106,449 | $1,323,161 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
35,000 | $1,066,800 |
All Filings in LFCR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $229,896 | 61,800 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $505,524 | 61,800 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $454,848 | 61,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $501,816 | 61,800 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $435,072 | 61,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $585,484 | 78,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $379,117 | 76,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $394,497 | 76,900 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $408,339 | 76,900 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $356,400 | 55,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $488,950 | 55,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $797,600 | 80,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $926,400 | 80,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,165,500 | 105,000 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $145,800 | 15,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $119,400 | 15,000 | Shares | Sole | 2020-08-31 | |
| No filing history on record for this holder in this stock. | ||||||